 | • レポートコード：GIR-107A14589 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ゴナドトロピン放出ホルモン（GnRH）作用薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ゴナドトロピン放出ホルモン（GnRH）作用薬の種類別市場規模（リュープロレリン、ゴセレリン、タルチレリン、ヒストレリン、その他）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ゴナドトロピン放出ホルモン（GnRH）作用薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、AstraZeneca、Ferring、TerSera Therapeutics、Takeda、LIVZON、Ipsen、Sanofi、Endo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リュープロレリン、ゴセレリン、タルチレリン、ヒストレリン、その他 ・用途別分析2016年-2026年：病院、薬局、その他 ・ゴナドトロピン放出ホルモン（GnRH）作用薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ゴナドトロピン放出ホルモン（GnRH）作用薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ゴナドトロピン放出ホルモン（GnRH）作用薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ゴナドトロピン放出ホルモン（GnRH）作用薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ゴナドトロピン放出ホルモン（GnRH）作用薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gonadotropin-releasing Hormone Agonist Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gonadotropin-releasing Hormone Agonist Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Gonadotropin-releasing Hormone Agonist Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gonadotropin-releasing Hormone Agonist Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Gonadotropin-releasing Hormone Agonist Drugs market are listed below:
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Gonadotropin-releasing Hormone Agonist Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, with price, sales, revenue and global market share of Gonadotropin-releasing Hormone Agonist Drugs in 2018 and 2019.
Chapter 3, the Gonadotropin-releasing Hormone Agonist Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gonadotropin-releasing Hormone Agonist Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Gonadotropin-releasing Hormone Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Gonadotropin-releasing Hormone Agonist Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gonadotropin-releasing Hormone Agonist Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size & Forecast
1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales in Value (2016-2026))
1.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume (2016-2026)
1.4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Gonadotropin-releasing Hormone Agonist Drugs Production Capacity Analysis
1.5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Total Production Capacity (2016-2026)
1.5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gonadotropin-releasing Hormone Agonist Drugs Market Drivers
1.6.2 Gonadotropin-releasing Hormone Agonist Drugs Market Restraints
1.6.3 Gonadotropin-releasing Hormone Agonist Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ferring
2.3.1 Ferring Details
2.3.2 Ferring Major Business
2.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.3.4 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 TerSera Therapeutics
2.4.1 TerSera Therapeutics Details
2.4.2 TerSera Therapeutics Major Business
2.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.5.4 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 LIVZON
2.6.1 LIVZON Details
2.6.2 LIVZON Major Business
2.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Ipsen
2.7.1 Ipsen Details
2.7.2 Ipsen Major Business
2.7.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.7.4 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Endo
2.9.1 Endo Details
2.9.2 Endo Major Business
2.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Product and Services
2.9.4 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Gonadotropin-releasing Hormone Agonist Drugs Sales by Manufacturer
3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gonadotropin-releasing Hormone Agonist Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer Market Share
3.4.2 Top 6 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer Market Share
3.5 Global Gonadotropin-releasing Hormone Agonist Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gonadotropin-releasing Hormone Agonist Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region
4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2016-2026)
4.2 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026)
4.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026)
4.4 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026)
4.5 South America Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026)
4.6 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Type (2016-2026)
5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2016-2026)
5.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Application (2016-2026)
6.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2016-2026)
6.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2026)
7.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2026)
7.3 North America Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country
7.3.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2026)
8.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2026)
8.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country
8.3.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region
9.3.1 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2026)
10.2 South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2026)
10.3 South America Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country
10.3.1 South America Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country
11.3.1 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gonadotropin-releasing Hormone Agonist Drugs Typical Distributors
12.3 Gonadotropin-releasing Hormone Agonist Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 6. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 10. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ferring Basic Information, Manufacturing Base and Competitors
Table 12. Ferring Major Business
Table 13. Ferring Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 14. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. TerSera Therapeutics Major Business
Table 17. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 18. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Takeda Basic Information, Manufacturing Base and Competitors
Table 20. Takeda Major Business
Table 21. Takeda Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 22. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. LIVZON Basic Information, Manufacturing Base and Competitors
Table 24. LIVZON Major Business
Table 25. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 26. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Ipsen Basic Information, Manufacturing Base and Competitors
Table 28. Ipsen Major Business
Table 29. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 30. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 34. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Endo Basic Information, Manufacturing Base and Competitors
Table 36. Endo Major Business
Table 37. Endo Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 38. Endo Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Gonadotropin-releasing Hormone Agonist Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Gonadotropin-releasing Hormone Agonist Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Gonadotropin-releasing Hormone Agonist Drugs Production Site of Key Manufacturer
Table 44. Gonadotropin-releasing Hormone Agonist Drugs New Entrant and Capacity Expansion Plans
Table 45. Gonadotropin-releasing Hormone Agonist Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2016-2021e) & (K Units)
Table 47. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2021-2026) & (K Units)
Table 48. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 51. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 55. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2021-2026) & (USD/Unit)
Table 56. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 57. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 58. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 61. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2021-2026) & (USD/Unit)
Table 62. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 63. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 64. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 67. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 68. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 69. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 70. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 72. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 76. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 86. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 87. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 88. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 91. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 92. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 93. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Gonadotropin-releasing Hormone Agonist Drugs Typical Distributors
Table 105. Gonadotropin-releasing Hormone Agonist Drugs Typical Customers
List of Figures
Figure 1. Gonadotropin-releasing Hormone Agonist Drugs Picture
Figure 2. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2020
Figure 3. Leuprorelin
Figure 4. Goserelin
Figure 5. Taltirelin
Figure 6. Histrelin
Figure 7. Other
Figure 8. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (2016-2026) & (K Units)
Figure 15. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Gonadotropin-releasing Hormone Agonist Drugs Production Capacity (2016-2026) & (K Units)
Figure 17. Global Gonadotropin-releasing Hormone Agonist Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Gonadotropin-releasing Hormone Agonist Drugs Market Drivers
Figure 19. Gonadotropin-releasing Hormone Agonist Drugs Market Restraints
Figure 20. Gonadotropin-releasing Hormone Agonist Drugs Market Trends
Figure 21. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturer in 2020
Figure 22. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturer in 2020
Figure 23. Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2016-2026)
Figure 27. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2016-2026)
Figure 28. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 31. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 34. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2016-2026)
Figure 35. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 37. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2016-2026)
Figure 38. Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 40. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 41. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 42. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 43. United States Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 47. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 48. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 49. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2016-2026)
Figure 59. China Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 66. South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界のゴナドトロピン放出ホルモン（GnRH）アゴニスト市場 2021：企業別、地域別、種類・用途別 The Gonadotropin-releasing Hormone Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 世界のエチレン放出化合物市場 2021：企業別、地域別、種類・用途別 The Ethylene Releasing Compounds market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の成長ホルモン阻害ホルモン市場 2021：企業別、地域別、種類・用途別 The Growth Hormone-inhibiting Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の注射可能生殖ホルモン市場 2021：企業別、地域別、種類・用途別 The Injectable Reproductive Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の副腎皮質刺激ホルモン受容体市場 2021：企業別、地域別、種類・用途別 The Adrenocorticotropic Hormone Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …